• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激素替代疗法的当前趋势:认知与应用

Current trends in hormone replacement therapy: perceptions and usage.

作者信息

Birkhäuser M H, Reinecke I

机构信息

Universitats-Frauenklinik Inselspital, Berne, Switzerland.

出版信息

Climacteric. 2008 Jun;11(3):192-200. doi: 10.1080/13697130802060455.

DOI:10.1080/13697130802060455
PMID:18568784
Abstract

OBJECTIVE

To determine whether physicians' confidence in the use of hormone replacement therapy (HRT) for climacteric symptoms has been affected by the negative media interpretation of data from landmark studies investigating HRT usage such as the Women's Health Initiative (WHI) study.

METHODS

A structured questionnaire was completed via the internet by European and US gynecologists, obstetrician/gynecologists and general practitioners - all experienced in treating women with climacteric symptoms.

RESULTS

Six hundred physicians completed the survey in six countries. Overall, 98% agreed that the menopause significantly affects quality of life and 97% considered that the majority/all of their patients experienced positive benefits from HRT. Most physicians (90%) believed the benefits of HRT outweigh the risks in suitable patients, and 92% would prescribe HRT for themselves/spouse/family. For treatment of atrophic vaginitis, 86% agreed that local estrogen was the most effective course of action. While 82% of participants were aware of the latest recommendations on low-dose HRT, and estrogen dose in particular, 67% cited lowering the progestogen dose as important. With regard to the recent negative media coverage on HRT, 78% of physicians felt this was unjustified.

CONCLUSIONS

These results provide reassurance that health-care professionals in Europe and the US, experienced in treating women with climacteric symptoms, have not lost confidence in HRT. Despite a consensus on the importance of lowering the dose of HRT and a focus on estrogen, there remains a need to heighten prescribers' awareness on the pivotal role that a lower progestogen dose plays in optimizing the risk-benefit profile.

摘要

目的

确定医生对使用激素替代疗法(HRT)治疗更年期症状的信心是否受到媒体对诸如妇女健康倡议(WHI)研究等调查HRT使用情况的里程碑式研究数据的负面解读的影响。

方法

欧洲和美国的妇科医生、妇产科医生和全科医生通过互联网完成了一份结构化问卷,他们都有治疗更年期症状女性的经验。

结果

六个国家的600名医生完成了调查。总体而言,98%的人认为更年期会显著影响生活质量,97%的人认为他们的大多数/所有患者都从HRT中获得了积极益处。大多数医生(90%)认为HRT对合适的患者益处大于风险,92%的医生会为自己/配偶/家人开HRT药物。对于萎缩性阴道炎的治疗,86%的人认为局部使用雌激素是最有效的治疗方法。虽然82%的参与者了解关于低剂量HRT的最新建议,特别是雌激素剂量,但67%的人认为降低孕激素剂量很重要。关于近期媒体对HRT的负面报道,78%的医生认为这是不合理的。

结论

这些结果表明,在欧洲和美国,有治疗更年期症状女性经验的医疗保健专业人员对HRT并没有失去信心。尽管在降低HRT剂量的重要性以及对雌激素的关注方面已达成共识,但仍有必要提高开处方者对较低孕激素剂量在优化风险效益比中所起关键作用的认识。

相似文献

1
Current trends in hormone replacement therapy: perceptions and usage.激素替代疗法的当前趋势:认知与应用
Climacteric. 2008 Jun;11(3):192-200. doi: 10.1080/13697130802060455.
2
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.更年期医学:欧洲更年期与男性更年期协会(EMAS)2004/2005年关于围绝经期和绝经后激素替代疗法的立场声明。
Maturitas. 2005 May 16;51(1):8-14. doi: 10.1016/j.maturitas.2005.02.019.
3
Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.妇女健康倡议(Women's Health Initiative)时代后的激素替代疗法。2003年2月24日至25日在马德拉岛丰沙尔举行的会议报告。
Climacteric. 2003 May;6 Suppl 1:11-36.
4
A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.一项关于妇产科医生的执业模式及对激素疗法态度的调查。
Menopause. 2006 May-Jun;13(3):434-41. doi: 10.1097/01.gme.0000185753.77704.65.
5
The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).妇女健康倡议对绝经后激素治疗中断的影响:明尼苏达心脏调查(2000 - 2002年)
J Womens Health (Larchmt). 2004 Nov;13(9):975-85. doi: 10.1089/jwh.2004.13.975.
6
After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.女性健康倡议之后:绝经后女性停用雌激素替代疗法的经历。
J Womens Health (Larchmt). 2004 May;13(4):438-42. doi: 10.1089/154099904323087132.
7
The attitude of gynecologists in São Paulo, Brazil 3 years after the Women's Health Initiative study.巴西圣保罗妇科医生在“女性健康倡议”研究开展3年后的态度。
Maturitas. 2007 Feb 20;56(2):129-41. doi: 10.1016/j.maturitas.2006.06.022. Epub 2006 Aug 8.
8
Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.妇女健康倡议研究对泰国更年期诊所就诊女性的激素替代疗法态度及接受度的影响。
J Med Assoc Thai. 2007 Apr;90(4):628-35.
9
Hormone replacement therapy: a survey of Ontario physicians' prescribing practices.激素替代疗法:安大略省医生处方实践调查。
CMAJ. 1999 Sep 21;161(6):695-8.
10
Assessment of the understanding of the risks and benefits of hormone replacement therapy (HRT) in primary care physicians.对基层医疗医生对激素替代疗法(HRT)风险和益处的理解情况的评估。
Am J Obstet Gynecol. 2005 Aug;193(2):551-6; discussion 556-8. doi: 10.1016/j.ajog.2005.03.061.

引用本文的文献

1
The relationship between menopausal hormone therapy and keratinocyte carcinoma: A review.更年期激素治疗与角质形成细胞癌之间的关系:一项综述。
Int J Womens Dermatol. 2018 Sep 15;5(1):8-13. doi: 10.1016/j.ijwd.2018.07.002. eCollection 2019 Feb.
2
Sources of information influencing the state-of-the-science gap in hormone replacement therapy usage.影响激素替代疗法使用方面科学现状差距的信息来源。
PLoS One. 2017 Feb 3;12(2):e0171189. doi: 10.1371/journal.pone.0171189. eCollection 2017.
3
Female Estrogen-Related Factors and Incidence of Basal Cell Carcinoma in a Nationwide US Cohort.
美国全国队列中女性雌激素相关因素与基底细胞癌发病率
J Clin Oncol. 2015 Dec 1;33(34):4058-65. doi: 10.1200/JCO.2015.62.0625. Epub 2015 Nov 2.
4
Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.患有心肌梗死的女性中激素替代疗法的使用和停用:一项全国性研究。
Br J Clin Pharmacol. 2011 Jan;71(1):105-15. doi: 10.1111/j.1365-2125.2010.03790.x.
5
Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study.绝经激素治疗与加利福尼亚教师研究中特定浸润性乳腺癌亚型的后续风险。
Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2366-78. doi: 10.1158/1055-9965.EPI-10-0162. Epub 2010 Aug 10.
6
Hormone use and lung cancer incidence: the Rancho Bernardo cohort study.激素使用与肺癌发病率:兰乔贝纳多队列研究
Menopause. 2009 Sep-Oct;16(5):1044-8. doi: 10.1097/gme.0b013e3181a1ba04.